The IGLON5 gene helps make a protein on the surface of nerve cells that supports how brain cells connect and communicate, especially in areas involved in sleep and movement. If this protein does not work normally, sleep behavior, balance, swallowing, and other automatic body functions can be affected. In medicine, this gene is best known because antibodies against the IgLON5 protein are linked to anti-IgLON5 disease, a rare neurologic condition. It is not a celebrity gene, but it has become more recognized in sleep medicine and neurology because of this condition.
What is a gene?
A gene is a section of DNA that holds instructions your cells can use to make molecules or regulate processes in the body. Some genes provide the information needed to produce proteins, the functional parts of cells. Other genes mostly help determine when certain processes happen, where they happen, and how strongly they take place. As a group, genes affect how the body develops and functions, and they can influence how you respond to food, stress, or medications. To explore this subject in greater depth, you can read more in the LearnHub.
Overview
IGLON5Gene function
What if the gene works
The IGLON5 gene helps make a protein on the surface of nerve cells. This protein supports how brain cells stick together, form connections, and communicate.
Risk
What if the gene does not work
Milder to more severe variants in the IGLON5 gene can lower how much of its protein is made or how well it works. This may weaken cell surface contacts between nerve cells and alter signaling between them.
Treatment
What does that mean for your treatment
No IGLON5-specific treatment or drug selection approach is currently established for people with a pathogenic variant in the IGLON5 gene.
Gene function
What if the gene works
In the brain, the IGLON5 gene helps nerve cells make orderly contact with each other. Its protein sits on the cell surface, where it supports steady communication and connection building. This helps explain the IGLON5 gene's function in the brain, where precise cell contact matters every day.
The IGLON5 gene makes a surface protein that helps nerve cells recognize and attach to nearby cells. This cell-to-cell contact supports the organized layout of brain tissue.
Its protein helps developing nerve cells extend and guide their branches. These branches later send and receive signals, so their growth needs to be well coordinated.
The IGLON5 gene supports the formation and upkeep of contact points between nerve cells. These contact points help brain networks stay connected so signals can pass in an orderly way.
What is a variant?
A genetic variant is a minor difference in the DNA sequence within a gene. These differences are common and are part of normal human diversity, including variations in appearance, metabolism, or the way the body responds to environmental influences. Many do not cause any noticeable effect and simply represent natural genetic variation. In some cases, though, a variant changes how a gene functions more substantially and can contribute to or cause a genetic condition.
Genetic variants
What if the gene does not work
Variants in the IGLON5 gene can change the shape of the IgLON5 protein, how stably it folds, and whether it reaches the cell surface and binds normally to partner proteins. Milder variants may only partly reduce stability or these interactions, while more disruptive variants can sharply lower the amount of usable protein or lead to a near-complete loss of function. This range helps explain why changes in the IGLON5 gene can affect protein function to different degrees.
How variants are linked to conditions
The IGLON5 gene does not yet have a broadly confirmed link to a specific inherited health condition, although research on IGLON5 gene variants linked to conditions is still developing. Anyone with a confirmed change in the IGLON5 gene should use their own test result, family history, and clinical findings with their doctor or genetic counselor to understand what it may mean.
A variant is not necessarily a diagnosis
Genetic variants are a common and normal feature of human biology. Most do not directly affect health and simply contribute to natural variation among people. For many genes, having a variant associated with a condition points to a possible link rather than a certain diagnosis, particularly when several genes and environmental influences also play a role. In some situations, though, one well-characterized variant in a particular gene is enough to confirm a diagnosis.
Are there things that can increase or change my risk?
There is not yet broadly confirmed evidence on specific lifestyle or environmental factors that clearly increase or reduce health risk related to the IGLON5 gene. Risk depends mainly on the specific genetic change, if one is present, and sometimes family history, so personal guidance from a doctor or genetic counselor can help put results in context.
Inheritance of IGLON5 variants
There is not yet a broadly confirmed, disease-associated inheritance pattern for the IGLON5 gene, so the answer to how IGLON5 gene variants are inherited is still developing. Current research has not established a single well-supported Mendelian pattern, such as autosomal dominant or autosomal recessive, for IGLON5-related health effects. The IGLON5 gene is located on chromosome 19, which is an autosome. That means every person inherits one copy of the IGLON5 gene from each parent.
What does my IGLON5 result mean for my family?
There is not a broadly confirmed inherited pattern linking the IGLON5 gene itself to a specific genetic condition in families. If you have an IGLON5 result and want to know what it could mean for relatives, a doctor or genetic counselor can help interpret that result in the context of your family history and symptoms.
Genetic information
Genetic testing
How you find out about variants
To find out whether you carry a variant in the IGLON5 gene, doctors use genetic testing for IGLON5 variants, usually on a blood or saliva sample. A lab reads the DNA sequence to look for changes and reports whether a variant was found.
When should I consider getting a genetic test?
There is not yet a broadly established clinical reason to have genetic testing focused on the IGLON5 gene. Testing decisions are usually based on your symptoms, other test results, and family history, and are best made with a doctor or genetic counselor.
A genetic result is only one part of your health story
A genetic finding can be informative, but how much it explains varies with the condition and the kind of variant found. Over time, many factors, including lifestyle, environment, age, and medical history, influence how the body functions. For some conditions, particularly those shaped by many genes, genetic information provides context rather than certainty and makes the most sense when viewed alongside other parts of care. In other situations, a genetic result can offer a clear answer. In areas like medication response, genetic results can also help put a person’s experience into context.
Pharmacogenetics
How variants shape your response to medicine
Genetic variation can affect how people respond to medicines. Small differences in DNA can change how the body breaks down a drug, how strongly it acts, or how sensitive someone is to side effects. This helps explain why the same treatment may work well for one person but less well for another, even when they take the same medication.
What is Pharmacogenetics?
Pharmacogenetics examines how genetic differences affect the way people respond to medications. It studies the relationship between genes and drugs to help explain why the same treatment may work differently from one person to another. With many medicines, genes can influence how strong a drug’s effects are or how the body processes it. This information can help support treatment decisions that are more informed and more individualized. More detail on this topic is available in the LearnHub.
Drugs influenced by the IGLON5 gene
When should I seek medical advice?
There is not yet a broadly confirmed role for this gene in predicting how medicines will work or which side effects may happen. Questions about treatment, new symptoms after starting a medicine, or concerns about side effects are best discussed with your doctor.
History
In the late 1990s and early 2000s, researchers identified the IGLON5 gene as part of the IgLON family, a group of genes active in the nervous system. At first, it attracted limited attention and was studied mainly in laboratory research on the brain. Scientific classifications changed as researchers learned more about the gene. Interest grew markedly in 2014, when doctors linked antibodies against the IGLON5 protein to a distinctive neurologic condition marked by sleep changes, movement symptoms, and later brain findings. From these first observations, research expanded steadily, and the IGLON5 gene became an important part of work exploring the overlap between immune-related illness and neurodegeneration. Since then, published case series and pathology studies have sharpened how IGLON5-related disease is recognized.